Vaccine nationalism and equitable access to COVID-19 pharmaceuticals: TRIPS Agreement under trial (again)

Secrecy, Monopoly, and Access to Pharmaceuticals in International Trade Law: Protection of Marketing Approval Data Under the TRIPs Agreement

Among the many trade conoicts that divide the postindustrial economies of Europe, the United States, Japan, and the Commonwealth from the less information-driven economies of the rest of the world, one of the most consequential is the debate over how to balance access to medicines with the intellectual property protection demanded by their developers. Among the many facets of this debate is the...

Unfair competition under the TRIPS agreement: protection of data submitted for the registration of pharmaceuticals.

Trade, TRIPS, and pharmaceuticals.

The World Trade Organization's Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) set global minimum standards for the protection of intellectual property, substantially increasing and expanding intellectual-property rights, and generated clear gains for the pharmaceutical industry and the developed world. The question of whether TRIPS generates gains for developing coun...

AIDS and TRIPS Pharmaceutical Patents, Generic Drugs and Public Health Under The TRIPS Agreement

The signing of the TRIPS agreement in 1994 heralded the world-wide enforcement of the type of intellectual property rights regime that had been established in the most developed countries. The arrival of this type of regime, which provides enlarged and powerful protection to patent-holders, coincided with the global development of the AIDS epidemic. This generated a series of new problems, part...

Access to Medicines : Solving the Export Problem under TRIPs

T year the WTO is supposed to address paragraph 6 of the Doha Declaration on the TRIPs Agreement and Public Health, and perhaps the larger issue of the rules under which countries can export health care technologies. The issues that are imperfectly raised in the Declaration are important, as they involve the ability of a country to seek an efficient supplier for a medicine or other health care ...